Sign inJoin waitlistJoin the waitlist

Biagio Ricciuti

Instructor in Medicine, Harvard Medical School · Mass General Brigham

Credentials: · · ·

History

Mass General Brigham
Present

Medical Oncology
2025–2027
Santa Maria della Misericordia Hospital
2022–2025
Perugia University Medical School
2009–2013

Research

Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non-Small Cell Lung Cancer
JAMA Oncology · 2020 · 397 citations
Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status
Journal of Thoracic Oncology · 2022 · First of 33 authors · 357 citations
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable
Journal for ImmunoTherapy of Cancer · 2019 · 353 citations

MA
Mark Awad
111 papers
Lynette Sholl
41 papers
Pasi Jänne
24 papers
AS
Adam Schoenfeld
22 papers · 9 as a fellow
Scott Rodig
22 papers
Abdul Naqash
20 papers · 6 as a fellow
AE
Arielle Elkrief
20 papers
BJ
Bruce Johnson
19 papers
VV
Victor Vaz
19 papers · 17 as a resident
John Heymach
17 papers
MG
Malini Gandhi
17 papers · 13 as a resident
Natalie Vokes
14 papers · 1 as a fellow

Clinical trials

A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma
Principal investigator · Terminated · Phase 2
Dana-Farber Cancer Institute
2017–2024